Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Covidien plc.

http://www.covidien.com

Latest From Covidien plc.

Medtronic CEO Omar Ishrak Announces Retirement; Geoff Martha Will Be New CEO

Ishrak will remain with the company as executive chairman. Geoff Martha, the current head of Medtronic’s restorative therapies group, will become president on 1 November and CEO in April 2020. Brett Wall, the current lead of the brain therapies business, will head the restorative therapies group.

Leadership Commercial

Start-Up Spotlight: Distalmotion Wants To Bring Cost-Effective, Focused Alternative To Robotic Surgery Market

Switzerland-based Distalmotion hopes to make its Dexter robotic surgery the standard of care in procedures that entail precise dissection and suturing and market itself as a more cost-effective alternative to Intuitive Surgical’s da Vinci system.

Start-up Spotlight Innovation

Market Brief: Global Market For Endoscopic Surgeries Will Reach $17.7Bn In 2023

The global market for endoscopic and pelvic surgery procedures is expected to reach $17.7bn in 2023, a CAGR of 6.4%, driven by patients' demand for less invasive surgeries and physicians' preference for minimally invasive surgeries versus open surgeries. By 2023, the number of general and pelvic endoscopic procedures performed globally will reach about 29.7 million, representing a CAGR of 3.6%.

Innovation Market Intelligence

Market Brief: Blood Gas Monitoring Systems Market Expected To Reach $4.9Bn By 2023

The global market for blood gas monitoring systems is expected to grow 6.1% annually to reach $4.9bn in 2023, driven by the rising prevalence of chronic diseases, the aging population, and pressure on medical device makers to introduce smart devices that improve outcomes while reducing cost of care.

Commercial Innovation
See All

Company Information

  • Industry
  • Medical Devices
    • Biomaterials
    • Consumables, Central Supplies
    • Diagnostic Imaging Equipment & Supplies
    • Monitoring Equipment & Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Surgical Sealants
  • Other Names / Subsidiaries
    • CV Ingenuity
    • Given Imaging, ev3 Inc., Sapheon Inc., Somanetics Corporation
UsernamePublicRestriction

Register